High copayments for novel therapies may reduce patients' medication adherenceUniversity of California, Los Angeles (UCLA), Health Sciences
Researchers at the University of East Anglia and the University of Cambridge have made an important discovery in the race to find treatments for obesity and related diseases, such as diabetes. A new study published today is the first to reveal the molecular structure of a protein called ‘Uncoupling protein 1’ (UCP1).
Anti-obesity medications, including semaglutide (Ozempic and Wegovy), can effectively help patients manage weight regained after bariatric surgery, a study led by UT Southwestern Medical Center researchers shows.
A reporter's PressPass is required to access this story until the embargo expires on 7-Jun-2023 4:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.
A reporter's PressPass is required to access this story until the embargo expires on 5-Jun-2023 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.
Mercy's Drs. Sabrina Barata and Sara Encisco are the featured guests on the hospital's monthly talk show, “Medoscopy,” airing Tuesday and Wednesday, June 20th and 21st, at 5:30 p.m. EST (www.facebook.com/MercyMedicalCenter).
New research has unlocked insights into how “good fat” tissue could potentially be harnessed to combat obesity and remove glucose from the blood, helping to control diabetes. Published today in Science Advances, the work is a collaboration between researchers with the Perelman School of Medicine at the University of Pennsylvania and University of Cambridge, Free University of Brussels and University of East Anglia.
Pediatric endocrinologist diagnose and treat conditions affecting the endocrine glands and hormones of children and adolescents. As one of the very few pediatric endocrinologists along the U.S.-Mexico border, Dr. Zerah works with children up to age 18 with endocrine disorders of growth, puberty, thyroid, calcium metabolism and diabetes.
One-third of adults in the U.S. with Type 2 diabetes may have symptomless or undetected cardiovascular disease.
The Endocrine Society has selected five recipients for its Early Investigator Awards.
A scientific team from the University of Barcelona and the CIBERobn has designed a strategy to fight obesity and diabetes in mice through ex vivo gene therapy which consists of implanting cells that have been manipulated and transformed in order to treat a disease. This is the first study to apply the ex vivo gene therapy technique to generate and implant cells that express the CPT1AM protein, an enzyme that plays a decisive role in many metabolic diseases such as obesity.
A reporter's PressPass is required to access this story until the embargo expires on 6-Jun-2023 2:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.
Researchers will delve into the latest research in diabetes, obesity, reproductive health and other aspects of endocrinology during the Endocrine Society’s ENDO 2023 news conferences June 15-18.
Researchers at Wilmer Eye Institute, Johns Hopkins Medicine say they have evidence that an experimental drug may prevent or slow vision loss in people with diabetes. The results are from a study that used mouse as well as human retinal organoids and eye cell lines.
Over 37 million Americans have diabetes, and 90-95% of that population are diagnosed with type 2 diabetes. Lifestyle interventions, such as a healthy diet and a regular physical activity program, are methods to manage diabetes.
Researchers at The University of Texas at El Paso have successfully mapped specific regions in the brain that are activated in association with changes in glucose, providing fundamental location information that could ultimately lead to more targeted therapies for people who struggle with conditions like diabetes.
Mayo Clinic researchers conducted a study within their health care system to identify factors associated with quality of care among rural and urban patients with diabetes. The study evaluated patient attainment of a five-component diabetic care metric, known as the D5 metric.
In APL Bioengineering, researchers design a novel algorithm for controlling implanted insulin pumps that accounts for the unique characteristics of individual patients. Their model, tested using an FDA-approved diabetes computer simulation, proves intraperitoneal (within the abdominal cavity) insulin delivery is fast and closely mimics natural physiological insulin delivery. They developed a model that can account for individual patient differences and validated a pump control algorithm that does not require meal announcement.
Scientists at Wake Forest University School of Medicine have uncovered a novel mechanism that shows increased sugar intake and elevations in blood glucose are sufficient to cause amyloid plaque buildup in the brain, which increases the risk of Alzheimer’s disease.
Canadian researchers have identified a new role for vitamin K and gamma-carboxylation in beta cells and their potentially protective role in diabetes, achieving a first in 15 years of basic research.
The new research findings, published in March in the Journal of the American College of Cardiology, used data from the Coronary Artery Risk Development in Young Adults (CARDIA), which recruited about 5,000 healthy young adults from four U.S. cities and followed them for 30 years. The researchers were able to calculate from this data the cumulative effect of individual risk factors, such as high blood pressure, diabetes, elevated cholesterol, and the additive effects of multiple risk factors that can cause cardiovascular disease.
The Faculty of Allied Health Sciences, Chulalongkorn University, has opened “MNET Center” to offer medical nutrition and exercise consultation by experts from four allied health areas. The Center, located on the 15th floor of the Chulapat 14 Building, is open every Monday, Wednesday, and Friday from 4:30 PM to 7:30 PM . Appointments are required.
Skin cancer is the most prevalent form of cancer in the United States, with over 5 million cases diagnosed annually. The Centers for Disease Control and Prevention reports that melanoma alone accounts for more than 8,000 deaths each year. Thankfully, skin cancer is highly preventable, making it crucial to prioritize protection. Below are some of the latest headlines in the Dermatology channel.
Katy Winckworth-Prejsnar, MPH, Senior Manager of Global Policy and Strategic Alliances for National Comprehensive Cancer Network (NCCN), to Co-Chair Non-Communicable Diseases Roundtable for the Global Health Council (GHC)
Researchers from Sanford Burnham Prebys and the Chinese University of Hong Kong have developed a computational approach to predict whether a person with type 2 diabetes will develop kidney disease. The findings could help doctors prevent or better manage kidney disease in people with type 2 diabetes.
A new study from Keck Medicine of USC published in the Annals of Internal Medicine shows that heavy alcohol use may be dramatically more damaging to the liver for people with metabolic syndrome.
It’s a common misconception that older adults need less sleep than those younger, but many get fewer hours due to insomnia and various health problems, including sleep apnea and heart trouble. In addition to a reduced quality of life, long-term health consequences of poor sleep include high blood pressure, weight gain, stroke, heart attack, diabetes, memory problems, and even increased risk of death, said Deborah Freeland, M.D., Assistant Professor of Internal Medicine and a member of UTSW’s Division of Geriatric Medicine.
In medicine and science, the term “pathogenesis” describes the origin and development of disease. There is not, however, a broadly accepted term to describe the other half of the equation: the process of healing and recovery.
Anzela Niraula, Ph.D., of the University of Washington in Seattle, won the Endocrine Society's 2023 Endocrine Images Art Competition for her image of the microglia mandala. This contest celebrates the beauty of endocrine science, and entries were judged based on aesthetic value and significance to endocrine research.
Not for public release
A reporter's PressPass is required to access this story until the embargo expires on 8-May-2023 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.
If you’re a health care provider treating people with Type 2 diabetes (T2D), University at Buffalo researcher Mehmet A. Eskan has this suggestion for you: check your patients’ teeth.
In a University of California, Irvine-led study, researchers have discovered small-molecule drugs with potential clinical utility in the treatment of age-related macular degeneration (AMD), diabetic retinopathy (DR), and retinitis pigmentosa (RP).
Fitterfly’s diabetes digital therapeutics program shows real-world effectiveness in improving glycemic control and weight management among people with type 2 diabetes mellitus
Asian Americans have significant differences in genetics, socioeconomic factors, culture, diet, lifestyle, health interventions and acculturation levels based on the Asian region of their ancestry that likely have unique effects on their risk for heart disease and Type 2 diabetes.
A group led by researchers at Baylor College of Medicine and University of Alabama at Birmingham took on the challenge of investigating the process that leads to neuropathy with the goal of identifying strategies to prevent or control it.
Researchers at the Department of Biology, University of Copenhagen, have now contributed to solving this problem for a specific gene called GCK. The study has just been published in Genome Biology.
A new study by researchers at the Friedman School of Nutrition Science and Policy at Tufts University and others, shows how bringing together coalitions of individuals from government, public health, healthcare, public education, and other arenas to address a public health issue--in this case early childhood obesity--can result in better policies, systems, and environments for change.
Through data-analysis, researchers found that people taking long siestas had higher body mass indexes and were more likely to have metabolic syndrome than those who did not take siestas.
The BD Diabetes Center at Atlantic Health System’s Goryeb Children’s Hospital and diabetes research and advocacy organization JDRF, partnered to distribute a video series focusing on helping teens and young adults overcome the emotional challenges associated with newly diagnosed type 1 diabetes.
Research to Prevent Blindness (RPB) announces two new grants to support high-impact vision research. The new grants are the: RPB / Tom Wertheimer Career Development Award in Data Science and RPB / Mary Tyler Moore Vision Initiative Physician-Scientist Award.
UC San Diego researchers describe a key player in the defense mechanism that safeguards against excessive insulin in the body, which can be as harmful as too little.
Researcher will discuss the study which involved a sleeping aid known as suvorexant that is already approved by the Food and Drug Administration (FDA) for insomnia, hints at the potential of sleep medications to slow or stop the progression of Alzheimer’s disease.
New research results suggest that the widely used diabetes drug metformin may be beneficial for recovering from short periods of severe food insecurity or anorexia.
The Endocrine Society today endorsed the Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act of 2023, a bipartisan insulin affordability bill introduced by Sens. Jeanne Shaheen (D-NH) and Susan Collins (R-ME). This legislation would cap out-of-pocket insulin costs for those with private insurance, ensure patients can share in insulin rebates and discounts, and promote competition in the insulin market.
Women with chronic hypertension and diabetes who were enrolled in an award-winning program for 12 months after childbirth were more likely to keep follow-up health care visits, which in turn led to improved care, according to initial findings of the program published in The Joint Commission Journal on Quality and Patient Safety.